1 active not recruiting, 1 completed, 1 not yet recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Perennial Allergic Rhinitis (PAR): new trials by email Literature Review of Perennial Allergic Rhinitis (PAR) trials Research Report on Perennial Allergic Rhinitis (PAR)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of CM512 Injection in Patients With Perennial Allergic Rhinitis on Background Therapy CM512, Placebo - Perennial Allergic Rhinitis (PAR) | Phase 2 | Not yet recruiting | Beijing Keymed Biosciences Co., Ltd. | 200 | 2026-10-01 | 2026-10-22 |
| A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1) LY3650150, Placebo, Standard therapy for INCS - Perennial Allergic Rhinitis (PAR) | Phase 3 | Active not recruiting | Eli Lilly and Company | 450 | 2024-04-26 | 2026-09-24 |
| Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Allergic Rhinitis Beclomethasone Dipropionate (BDP) Nasal Aerosol - Perennial Allergic Rhinitis (PAR) | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 824 | 2012-07-01 | 2014-04-15 |
Rhinitis, Allergic, Perennial (3)
Hypersensitivity (3) · Hypersensitivity, Immediate (3) · Immune System Diseases (3) · Nose Diseases (3) · Otorhinolaryngologic Diseases (3) · Respiratory Hypersensitivity (3) · Respiratory Tract Diseases (3) · Rhinitis (3) · Rhinitis, Allergic (3)
Beclomethasone (1) · Nasal Sprays (1) · Standard of Care (1) · alpha-ketoisovalerate dehydrogenase phosphatase (1)
Beijing Keymed Biosciences Co., Ltd. (1) · Eli Lilly and Company (1) · Teva Branded Pharmaceutical Products R&D, Inc. (1)
China (2) · United States (2) · Belgium (1) · Germany (1) · Poland (1) · South Korea (1)
Mark Lepore, MD (1)
2023 (1)